Literature DB >> 18312467

Reduction of human T-cell leukemia virus type-1 infection in mice lacking nuclear factor-kappaB-inducing kinase.

Takayuki Nitta1, Masakazu Tanaka, Binlian Sun, Eiji Sugihara, Mako Kimura, Yuhei Kamada, Hideto Takahashi, Shuji Hanai, Shi-Wen Jiang, Jun-ichi Fujisawa, Masanao Miwa.   

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) causes adult T-cell leukemia and inflammatory disorders. Aberrant activation of nuclear factor-kappaB (NF-kappaB) has been linked to HTLV-1 pathogenesis and to various kinds of cancers, including adult T-cell leukemia. NF-kappaB-inducing kinase (NIK) is critical for non-canonical activation of NF-kappaB and for the development of lymphoid organs. HTLV-1 activates NF-kappaB by the non-canonical pathway, but examination of the role of NIK in proliferation of HTLV-1-infected cells in vivo has been hindered by lack of a suitable animal model. Alymphoplasia (aly/aly) mice bear a mutation of NIK, resulting in defects in the development of lymphoid organs and severe deficiencies in both humoral and cell-mediated immunity. In the present study we therefore used a mouse model of HTLV-1 infection with aly/aly mice. The number of HTLV-1-infected cells in the reservoir organs in aly/aly mice was significantly smaller than in the control group 1 month after infection. In addition, aly/aly mice did not maintain provirus for 1 year and antibodies against HTLV-1 were undetectable. These results demonstrate that the absence of functional NIK impairs primary HTLV-1 proliferation and abolishes the maintenance of provirus. Interestingly, clonal proliferation of HTLV-1-infected mouse cells was not detected in aly/aly mice, which is consistent with the lack of HTLV-1 persistence. These observations imply that the clonal proliferation of HTLV-1-infected cells in secondary lymphoid organs might be important for HTLV-1 persistence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18312467     DOI: 10.1111/j.1349-7006.2008.00766.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  8 in total

1.  Route of primary HTLV-1 infection regulates HTLV-1 distribution in reservoir organs of infected mice.

Authors:  Masakazu Tanaka; Takayuki Nitta; Binlian Sun; Jun-Ichi Fujisawa; Masanao Miwa
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

2.  Animals Models of Human T Cell Leukemia Virus Type I Leukemogenesis.

Authors:  Stefan Niewiesk
Journal:  ILAR J       Date:  2016

Review 3.  Animal Models Utilized in HTLV-1 Research.

Authors:  Amanda R Panfil; Jacob J Al-Saleem; Patrick L Green
Journal:  Virology (Auckl)       Date:  2013-11-18

Review 4.  The intricate interplay between RNA viruses and NF-κB.

Authors:  M Lienhard Schmitz; Michael Kracht; Vera V Saul
Journal:  Biochim Biophys Acta       Date:  2014-08-10

Review 5.  The utilization of humanized mouse models for the study of human retroviral infections.

Authors:  Rachel Van Duyne; Caitlin Pedati; Irene Guendel; Lawrence Carpio; Kylene Kehn-Hall; Mohammed Saifuddin; Fatah Kashanchi
Journal:  Retrovirology       Date:  2009-08-12       Impact factor: 4.602

6.  Animal models on HTLV-1 and related viruses: what did we learn?

Authors:  Hiba El Hajj; Rihab Nasr; Youmna Kfoury; Zeina Dassouki; Roudaina Nasser; Ghada Kchour; Olivier Hermine; Hugues de Thé; Ali Bazarbachi
Journal:  Front Microbiol       Date:  2012-09-21       Impact factor: 5.640

7.  Involvement of CD4⁺ Foxp3⁺ regulatory T cells in persistence of Leishmania donovani in the liver of alymphoplastic aly/aly mice.

Authors:  Saruda Tiwananthagorn; Kazuya Iwabuchi; Manabu Ato; Tatsuya Sakurai; Hirotomo Kato; Ken Katakura
Journal:  PLoS Negl Trop Dis       Date:  2012-08-21

Review 8.  Mouse Models That Enhanced Our Understanding of Adult T Cell Leukemia.

Authors:  Sara Moodad; Abdou Akkouche; Rita Hleihel; Nadine Darwiche; Marwan El-Sabban; Ali Bazarbachi; Hiba El Hajj
Journal:  Front Microbiol       Date:  2018-03-28       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.